300 related articles for article (PubMed ID: 29604467)
1. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.
Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S
Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467
[TBL] [Abstract][Full Text] [Related]
2. Association between SGK1 and α-synuclein in skeletal muscle in an MPTP-induced Parkinson's disease model.
Heo EJ; Lee Y; Hyung Seo M; Yeo S
Neurosci Lett; 2023 Sep; 814():137464. PubMed ID: 37634811
[TBL] [Abstract][Full Text] [Related]
3.
Seo MH; Yeo S
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502283
[TBL] [Abstract][Full Text] [Related]
4. MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons.
Kowall NW; Hantraye P; Brouillet E; Beal MF; McKee AC; Ferrante RJ
Neuroreport; 2000 Jan; 11(1):211-3. PubMed ID: 10683860
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.
Dong Z; Ferger B; Feldon J; Büeler H
J Neurobiol; 2002 Oct; 53(1):1-10. PubMed ID: 12360578
[TBL] [Abstract][Full Text] [Related]
6. Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease.
Lv Z; Jiang H; Xu H; Song N; Xie J
J Neural Transm (Vienna); 2011 Mar; 118(3):361-9. PubMed ID: 20556443
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of TorsinA as a target for Parkinson disease therapy in mouse models.
Li X; Lee J; Parsons D; Janaurajs K; Standaert DG
PLoS One; 2012; 7(11):e50063. PubMed ID: 23185535
[TBL] [Abstract][Full Text] [Related]
8. The mouse MPTP model: gene expression changes in dopaminergic neurons.
Kühn K; Wellen J; Link N; Maskri L; Lübbert H; Stichel CC
Eur J Neurosci; 2003 Jan; 17(1):1-12. PubMed ID: 12534964
[TBL] [Abstract][Full Text] [Related]
9. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.
Vila M; Vukosavic S; Jackson-Lewis V; Neystat M; Jakowec M; Przedborski S
J Neurochem; 2000 Feb; 74(2):721-9. PubMed ID: 10646524
[TBL] [Abstract][Full Text] [Related]
10. α-Synuclein Expression Is Preserved in Substantia Nigra GABAergic Fibers of Young and Aged Neurotoxin-Treated Rhesus Monkeys.
Vermilyea SC; Guthrie S; Hernandez I; Bondarenko V; Emborg ME
Cell Transplant; 2019 Apr; 28(4):379-387. PubMed ID: 30857404
[TBL] [Abstract][Full Text] [Related]
11. Association between Decreased SGK1 and Increased Intestinal α-Synuclein in an MPTP Mouse Model of Parkinson's Disease.
Seo MH; Kwon D; Kim SH; Yeo S
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003598
[TBL] [Abstract][Full Text] [Related]
12. Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway.
Jo MG; Ikram M; Jo MH; Yoo L; Chung KC; Nah SY; Hwang H; Rhim H; Kim MO
Mol Neurobiol; 2019 Jan; 56(1):39-55. PubMed ID: 29675576
[TBL] [Abstract][Full Text] [Related]
13. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice.
Robertson DC; Schmidt O; Ninkina N; Jones PA; Sharkey J; Buchman VL
J Neurochem; 2004 Jun; 89(5):1126-36. PubMed ID: 15147505
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model.
Hayashita-Kinoh H; Yamada M; Yokota T; Mizuno Y; Mochizuki H
Biochem Biophys Res Commun; 2006 Mar; 341(4):1088-95. PubMed ID: 16460685
[TBL] [Abstract][Full Text] [Related]
15. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions.
Gibrat C; Saint-Pierre M; Bousquet M; Lévesque D; Rouillard C; Cicchetti F
J Neurochem; 2009 Jun; 109(5):1469-82. PubMed ID: 19457163
[TBL] [Abstract][Full Text] [Related]
16. Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.
Benner EJ; Banerjee R; Reynolds AD; Sherman S; Pisarev VM; Tsiperson V; Nemachek C; Ciborowski P; Przedborski S; Mosley RL; Gendelman HE
PLoS One; 2008 Jan; 3(1):e1376. PubMed ID: 18167537
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's disease.
Thomas B; Banerjee R; Starkova NN; Zhang SF; Calingasan NY; Yang L; Wille E; Lorenzo BJ; Ho DJ; Beal MF; Starkov A
Antioxid Redox Signal; 2012 May; 16(9):855-68. PubMed ID: 21529244
[TBL] [Abstract][Full Text] [Related]
18. Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons.
Hong J; Sha S; Zhou L; Wang C; Yin J; Chen L
Cell Death Dis; 2015 Jul; 6(7):e1832. PubMed ID: 26203861
[TBL] [Abstract][Full Text] [Related]
19. N(ɛ)-(carboxymethyl)lysine linkage to α-synuclein and involvement of advanced glycation end products in α-synuclein deposits in an MPTP-intoxicated mouse model.
Choi YG; Lim S
Biochimie; 2010 Oct; 92(10):1379-86. PubMed ID: 20624443
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways.
Park JS; Choe K; Lee HJ; Park TJ; Kim MO
J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
